Jonathan Drachman

2013 - Seattle Genetics

In 2013, Jonathan Drachman earned a total compensation of $2.2M as Chief Medical Officer at Seattle Genetics, a 52% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,864
Option Awards$692,434
Salary$383,267
Stock Awards$904,041
Other$8,130
Total$2,168,736

Drachman received $904K in stock awards, accounting for 42% of the total pay in 2013.

Drachman also received $180.9K in non-equity incentive plan, $692.4K in option awards, $383.3K in salary and $8.1K in other compensation.

Rankings

In 2013, Jonathan Drachman's compensation ranked 3,628th out of 12,286 executives tracked by ExecPay. In other words, Drachman earned more than 70.5% of executives.

ClassificationRankingPercentile
All
3,628
out of 12,286
71st
Division
Manufacturing
1,231
out of 4,612
73rd
Major group
Chemicals And Allied Products
334
out of 1,466
77th
Industry group
Drugs
234
out of 1,160
80th
Industry
Biological Products, Except Diagnostic Substances
32
out of 200
84th
Source: SEC filing on April 6, 2016.

Drachman's colleagues

We found five more compensation records of executives who worked with Jonathan Drachman at Seattle Genetics in 2013.

2013

Clay Siegall

Seattle Genetics

Chief Executive Officer

2013

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2013

Todd Simpson

Seattle Genetics

Chief Financial Officer

2013

Vaughn Himes

Seattle Genetics

EVP, Technical Operations

2013

Christopher Boerner

Seattle Genetics

Former EVP, Commercial

News

You may also like